Idarubicin Hydrochloride



Indications and Reactions:

Role Indications Reactions
Primary
Acute Myeloid Leukaemia 50.0%
Acute Lymphocytic Leukaemia 16.7%
Acute Promyelocytic Leukaemia 14.6%
Leukaemia 6.3%
Oesophageal Varices Haemorrhage 4.2%
Acute Myelomonocytic Leukaemia 2.1%
Antifungal Prophylaxis 2.1%
Conjunctivitis 2.1%
Hypertension 2.1%
Endocarditis 10.0%
Haematochezia 10.0%
Haematuria 10.0%
Rash Generalised 10.0%
Sinus Tachycardia 10.0%
Acute Pulmonary Oedema 5.0%
Cerebellar Ataxia 5.0%
Chronic Myelomonocytic Leukaemia 5.0%
Multi-organ Failure 5.0%
Neck Pain 5.0%
Neutropenic Colitis 5.0%
Pancytopenia 5.0%
Respiratory Failure 5.0%
Sinus Bradycardia 5.0%
Vomiting 5.0%
Secondary
Acute Myeloid Leukaemia 26.6%
Pyrexia 13.0%
Acute Promyelocytic Leukaemia 10.5%
Prophylaxis 7.7%
Myelodysplastic Syndrome 5.5%
Acute Lymphocytic Leukaemia 4.8%
Nausea 4.6%
Vomiting 4.6%
Product Used For Unknown Indication 3.3%
Chloroma 2.6%
Diffuse Large B-cell Lymphoma 2.6%
Acute Myelomonocytic Leukaemia 2.4%
Bipolar Disorder 2.0%
Body Temperature Increased 2.0%
Non-hodgkin's Lymphoma 1.8%
Acute Monocytic Leukaemia 1.3%
Infection Prophylaxis 1.3%
Pain 1.3%
Sleep Disorder 1.1%
Acute Leukaemia 0.9%
Sepsis 10.0%
Myalgia 8.0%
Vomiting 8.0%
Benign Intracranial Hypertension 6.0%
Condition Aggravated 6.0%
Myocardial Infarction 6.0%
Sinus Bradycardia 6.0%
Endocarditis 4.0%
Febrile Neutropenia 4.0%
Hepatic Function Abnormal 4.0%
Hepatocellular Injury 4.0%
Hyperbilirubinaemia 4.0%
Neutropenia 4.0%
Neutropenic Colitis 4.0%
Pleural Effusion 4.0%
Pneumonia 4.0%
Pulmonary Mycosis 4.0%
Septic Shock 4.0%
Venoocclusive Liver Disease 4.0%
Acute Febrile Neutrophilic Dermatosis 2.0%
Concomitant
Acute Myeloid Leukaemia 18.8%
Product Used For Unknown Indication 12.8%
Acute Promyelocytic Leukaemia 11.9%
Prophylaxis 10.6%
Pyrexia 4.6%
Antifungal Prophylaxis 4.2%
Prophylaxis Of Nausea And Vomiting 4.0%
Prophylaxis Against Graft Versus Host Disease 3.8%
Acute Monocytic Leukaemia 2.9%
Allergy Prophylaxis 2.9%
Bone Marrow Conditioning Regimen 2.7%
Febrile Neutropenia 2.7%
Infection Prophylaxis 2.7%
Premedication 2.7%
Abdominal Pain 2.2%
Hypertension 2.2%
Insomnia 2.2%
Liver Abscess 2.2%
Herpes Zoster 2.0%
Vomiting 1.8%
Interstitial Lung Disease 22.2%
Vomiting 11.1%
Drug Ineffective 6.7%
Weight Increased 6.7%
Disseminated Intravascular Coagulation 4.4%
Febrile Neutropenia 4.4%
Neutropenia 4.4%
Pancreatitis Acute 4.4%
Renal Failure 4.4%
Respiratory Failure 4.4%
Syncope 4.4%
White Blood Cell Count Decreased 4.4%
Acute Graft Versus Host Disease In Skin 2.2%
Bronchitis 2.2%
Coagulopathy 2.2%
Drug Administration Error 2.2%
Drug Resistance 2.2%
Eosinophilic Pneumonia 2.2%
Hiccups 2.2%
Hyperbilirubinaemia 2.2%
Interacting
Acute Myeloid Leukaemia 31.3%
Prophylaxis 15.6%
Febrile Neutropenia 9.4%
Pain 9.4%
Drug Use For Unknown Indication 6.3%
Anxiety Disorder 5.2%
Nausea 5.2%
Oedema 5.2%
Vomiting 5.2%
Antifungal Prophylaxis 4.2%
Menorrhagia 3.1%
Drug Interaction 30.0%
Cerebellar Syndrome 20.0%
Dysarthria 20.0%
Menorrhagia 20.0%
Device Occlusion 10.0%